European Archives - Page 1231 of 1561 - European Medical Journal

What is the Best Food for Heart Health?

Food is once again under the spotlight as a new meta-analysis has delved into the risks and benefits of several food types and their links with heart…

A Bioengineered Left Heart Ventricle Model

A three-dimensional (3D) model of a human left heart ventricle has been successfully bioengineered by researchers at Harvard University, Cambridge…

Genetic Screen Could Predict Risk of Osteoporosis

Osteoporosis and fracture risk could be predicted early on through a genetic screen, following the discovery of 899 regions in the human genome…

“Cracking the launch code has become increasingly important for commercial success”

Ricky Suchak is a Director, Marketing at Sandoz, for both retail and institutional product portfolio. Suchak has more than 13 years of progressive…

Increasing Natural Substance in the Blood Could Help Treat Depression

Depression could potentially be treated by boosting blood levels of a substance produced naturally in the body called acetyl-L-carnitine, according to…

European Medical Journal Presents: EMJ Hematology 6.1

The European Medical Journal has published the latest edition of the EMJ Hematology eJournal. Click here to find out more

Study Could Help Overcome Resistance to a Common Cancer Treatment

Cancer cell resistance to PARP inhibitor therapy could be overcome following the discovery of various mechanisms that lay behind this resistance. The…

NGS in PH+ LEUKEMIA: WATCH AN INTERVIEW WITH DR SOVERINI

Dr Simona Soverini discusses early molecular response, next-generation sequencing, and the impact of tyrosine kinase inhibitor-resistant mutations in…

Planning Your Next Move in Philadelphia Chromosome Positive Leukaemias

The meeting was arranged as a series of conversations between experts, following a question and answer format with two speakers in each presentation…

Polymorphisms in Multidrug Resistance Transporter Genes Affect the Duration of Molecular Response to Nilotinib in Chronic Myeloid Leukaemia Patients

Despite the high efficacy and improved clinical response of nilotinib in chronic myeloid leukaemia (CML), there is still a significant proportion of…